Cerecyte Coil Trial
Open Access
- 1 October 2012
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 43 (10), 2544-2550
- https://doi.org/10.1161/strokeaha.112.657254
Abstract
Background and Purpose—: We report the primary outcome of the Cerecyte Coil Trial, a randomized trial to determine whether polymer-loaded Cerecyte coils compared with Micrus bare platinum coils improved the proportion of patients with angiographic occlusion of the aneurysm at 6 months when assessed by a core laboratory. The secondary objectives were to compare the clinical outcomes and retreatment rates in the 2 groups. Methods—: Five hundred patients between 18 and 70 years of age with a ruptured or unruptured target aneurysm were randomized to be treated with either Cerecyte or bare platinum coils in 23 centers worldwide. Two hundred forty-nine patients were assigned to Cerecyte coils and 251 to bare platinum coils. Analysis was by intention to treat. Results—: Four hundred ninety-four patients were eligible for analysis. Four hundred eighty-one patients underwent coil treatment of their aneurysm, 227 patients with recently ruptured aneurysms and 254 with unruptured aneurysms. Four hundred thirty-three follow-up angiograms were assessed by the core laboratory; 127 of 215 (59%) and 118 of 218 (54%) in the Cerecyte and bare platinum groups, respectively, fulfilled the trial prespecified definition of success, namely that the treated aneurysm showed complete angiographic occlusion, had stable neck remnant, or improved in angiographic appearance compared with the end-of-treatment angiogram ( P =0.17). Late retreatment was performed in 25 of 452 (5.5%) patients, 17 (7.7%) Cerecyte versus 8 (3.5%) bare platinum ( P =0.064; range, 4–34 months). The clinical outcomes did not differ between the groups. Conclusion—: There was no significant difference at 6 months in the angiographic outcomes between Cerecyte coils and bare platinum coils when assessed by the core laboratory. Clinical Trial Registration Information—: URL: www.controlled-trials.com . Unique Identifier: ISRCTN82461286.Keywords
This publication has 14 references indexed in Scilit:
- Cerecyte Coil Trial: Procedural Safety and Clinical Outcomes in Patients with Ruptured and Unruptured Intracranial AneurysmsAmerican Journal Of Neuroradiology, 2011
- Outcomes of Endovascular Treatments of Aneurysms: Observer Variability and Implications for Interpreting Case Series and Planning Randomized TrialsAmerican Journal Of Neuroradiology, 2011
- Hydrogel-coated coils versus bare platinum coils for the endovascular treatment of intracranial aneurysms (HELPS): a randomised controlled trialThe Lancet, 2011
- Observer Agreement Regarding the Necessity of Retreatment of Previously Coiled Recurrent Cerebral AneurysmsAmerican Journal Of Neuroradiology, 2011
- Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the International Subarachnoid Aneurysm Trial (ISAT): long-term follow-upThe Lancet Neurology, 2009
- Dangerous Advances in Measurements from Digital Subtraction Angiography: When Is a Millimeter Not a Millimeter?: Fig 1.American Journal Of Neuroradiology, 2008
- INITIAL EXPERIENCE WITH BIOACTIVE CERECYTE DETACHABLE COILSNeurosurgery, 2008
- Predictors of Rehemorrhage After Treatment of Ruptured Intracranial AneurysmsStroke, 2008
- Single-Center Experience of Cerecyte Coils in the Treatment of Intracranial Aneurysms: Initial Experience and Early Follow-Up ResultsAmerican Journal Of Neuroradiology, 2007
- Endovascular Occlusion of Aneurysms Using a New Bioactive CoilStroke, 2007